Synthesizing the recombinant Human EGLN1 protein generally involves integrating the DNA fragment that encodes the Human EGLN1 protein (177-426aa) into a plasmid, introducing the recombinant plasmid into e.coli cells, followed by the selection and culturing of positive e.coli cells, induction of protein expression, and subsequent cell lysis. A N-terminal 10xHis tag and C-terminal Myc tag is fused to the protein. The protein is purified through affinity purification, and SDS-PAGE analysis is conducted to confirm the presence of the protein and determine its purity. The protein's purity surpasses 85%.
Email: support@cusabio.com
Distributors Worldwide